0 NASDAQ Companies - October 24, 2019eXp Realty Names Jason Gesing as CEOBELLINGHAM, Wash., Oct. 24, 2019 (GLOBE NEWSWIRE) — eXp Realty, The Real Estate Cloud Brokerage™ and a subsidiary of eXp […]Read More
0 NASDAQ Companies - October 24, 2019ACNB Corporation Declares Fourth Quarter Cash DividendGETTYSBURG, Pa., Oct. 24, 2019 (GLOBE NEWSWIRE) — The Board of Directors of ACNB Corporation approved and declared the payment […]Read More
0 NASDAQ Companies - October 24, 2019KVH Ships 10,000th VSAT System for Global Maritime ConnectivityMIDDLETOWN, R.I., Oct. 24, 2019 (GLOBE NEWSWIRE) — KVH Industries, Inc., (Nasdaq: KVHI), a leader in mobile connectivity, announced today […]Read More
0 NASDAQ Companies - October 24, 2019BrainStorm Cell Therapeutics’ President and CEO to be Featured as Keynote Speaker at Cell Series UK 2019NEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in the development of […]Read More
0 NASDAQ Companies - October 24, 2019‘Going From Broke’ Exceeds One Million Views on Crackle in Just Five DaysNEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), a growing media […]Read More
0 TSX News - October 24, 2019Bombardier celebrates 25th anniversary of Germany’s first automatic people mover systemINNOVIA APM vehicles carry twelve million passengers annually at Frankfurt am Main Airport – with almost 100 percent reliabilityThe system’s […]Read More
0 NASDAQ Companies - October 24, 2019iQIYI to Report Third Quarter 2019 Financial Results on November 6, 2019BEIJING, Oct. 24, 2019 (GLOBE NEWSWIRE) — iQIYI, Inc. (NASDAQ: IQ) (“iQIYI” or the “Company”), an innovative market-leading online entertainment […]Read More
0 NASDAQ Companies - October 24, 2019Predictive Oncology: Helomics to present initial findings from its analysis of UK 100,000 Genomes Project data towards its goal of building AI-driven predictive models of ovarian cancerMINNEAPOLIS, Oct. 24, 2019 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a company focused on […]Read More
0 NASDAQ Companies - October 24, 2019Mustang Bio Announces Dosing of First Participant in Phase 1 Clinical Trial of MB-108 (Oncolytic Virus C134) to Treat GlioblastomaNEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on […]Read More
0 NASDAQ Companies - October 24, 2019Fortress Biotech to Participate in the 5th Annual Dawson James Small Cap Growth ConferenceNEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on […]Read More